Relapsed or Refractory Acute Myeloid Leukemia (AML)
9 clinical trials · Condition
◉ Watch Relapsed or Refractory Acute Myeloid Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia (NCT05345938) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-06-14 |
| A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05241093) | Tarapeutics Science Inc. | 2022-03-29 |
| A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05241106) | Tarapeutics Science Inc. | 2021-09-29 |
| Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies. (NCT03218683) | AstraZeneca | 2017-08-02 |
| Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation (NCT02074839) | Institut de Recherches Internationales Servier | 2014-03-01 |
Track Relapsed or Refractory Acute Myeloid Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.